Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Abstract Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Advers...

Full description

Bibliographic Details
Main Authors: Isaac V. Cohen, Tigran Makunts, Rabia Atayee, Ruben Abagyan
Format: Article
Language:English
Published: Nature Portfolio 2017-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-01590-x